Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

LGVN

Longeveron (LGVN)

Longeveron Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LGVN
DateTimeSourceHeadlineSymbolCompany
04/08/20225:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
04/08/20225:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
04/06/20225:01PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LGVNLongeveron Inc
04/05/20224:29PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LGVNLongeveron Inc
04/05/20228:00AMGlobeNewswire Inc.Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical OfficerNASDAQ:LGVNLongeveron Inc
04/02/20225:05AMTipRanksLongeveron (LGVN) Receives a Buy from Maxim GroupNASDAQ:LGVNLongeveron Inc
03/31/20228:28AMInvestorsHub NewsWireLongeveron publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer's Disease in Alzheimer's & Dementia©: The Journal of the Alzheimer's AssociationNASDAQ:LGVNLongeveron Inc
03/31/20228:00AMGlobeNewswire Inc.Longeveron Publishes Peer Reviewed Study of Phase 1 Trial Results of Lomecel-B for Alzheimer’s Disease in Alzheimer’s & Dementia®: The Journal of the Alzheimer’s AssociationNASDAQ:LGVNLongeveron Inc
03/25/20228:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
03/24/20228:00AMGlobeNewswire Inc.Longeveron Presents at Second Euro-Geroscience ConferenceNASDAQ:LGVNLongeveron Inc
03/15/20228:00AMGlobeNewswire Inc.Longeveron to Present at Oppenheimer 32nd Annual Healthcare ConferenceNASDAQ:LGVNLongeveron Inc
03/11/20225:01PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:LGVNLongeveron Inc
03/11/20228:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
03/11/20228:00AMGlobeNewswire Inc.Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational ProgressNASDAQ:LGVNLongeveron Inc
03/07/20228:00AMGlobeNewswire Inc.Longeveron to Announce Fourth Quarter and Full Year 2021 Financial Results, on March 11, 2022NASDAQ:LGVNLongeveron Inc
03/02/20228:00AMGlobeNewswire Inc.Longeveron to Present at Q1 Virtual Investor Summit ConferenceNASDAQ:LGVNLongeveron Inc
02/17/20224:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
02/17/20228:00AMGlobeNewswire Inc.Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of DirectorsNASDAQ:LGVNLongeveron Inc
02/09/20225:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
01/25/20228:00AMGlobeNewswire Inc.Longeveron to Participate in Phacilitate Advanced Therapies WeekNASDAQ:LGVNLongeveron Inc
01/12/20228:00AMGlobeNewswire Inc.Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and AgingNASDAQ:LGVNLongeveron Inc
01/10/202210:39AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LGVNLongeveron Inc
01/05/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
01/05/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
01/05/20225:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LGVNLongeveron Inc
01/05/20228:08AMInvestorsHub NewsWireLongeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer's DiseaseNASDAQ:LGVNLongeveron Inc
01/05/20228:00AMGlobeNewswire Inc.Longeveron Announces Initiation of Phase 2a Clinical Trial of Lomecel-B for the Treatment of Alzheimer’s DiseaseNASDAQ:LGVNLongeveron Inc
01/04/20228:00AMGlobeNewswire Inc.Longeveron to Participate in the H.C. Wainwright BioConnect 2022 Virtual ConferenceNASDAQ:LGVNLongeveron Inc
12/23/20216:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LGVNLongeveron Inc
12/22/20215:07PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:LGVNLongeveron Inc
 Showing the most relevant articles for your search:NASDAQ:LGVN

Your Recent History

Delayed Upgrade Clock